Fate Therapeutics Announces Proposed Public Offering of Common Stock

Go back to Fate Therapeutics Announces Proposed Public Offering of Common Stock
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.45 -0.2 (7.55%)
Previous Close $2.65    52 Week High $4.76 
Open $2.65    52 Week Low $1.46 
Day High $2.65    P/E N/A 
Day Low $2.44    EPS $-1.91 
Volume 1,565,754